Ipsos Healthcare Forecasts Stronger Insights for Pharma Companies

Chris Schneider Takes on Senior Level Strategy Role at Ipsos Healthcare

Thursday, August 15, 2013

New York, NY – Senior research expert Chris Schneider has joined Ipsos Healthcare as Senior Vice President, Commercial Strategy and Forecasting.

Chris 
Schneider

“With a background in both research firms and pharmaceutical companies, Chris brings a wealth of expertise to our team, with a holistic view of what our clients need and what we can help them achieve,” says Elys Roberts, President of Ipsos Healthcare, North America. “In his role at Ipsos Healthcare, Chris will help our clients identify new opportunities, assess the value of new assets, define their strategies, and plan for the future. And he will be supported by one of the largest and fastest growing teams in our industry. I’m pleased to welcome Chris to our team.”

Chris Schneider brings more than 12 years of broad BioPharma experience from a variety of commercial strategy and analytical roles on both the client and agency sides of the business.

In his most recent role prior to joining Ipsos, Schneider led diverse teams of qualitative and quantitative market researchers at another healthcare market research agency and before that, spent 10 years on the client-side of the industry at Roche and Pfizer in roles within strategic pricing and customer development, business development/licensing, and finance.

“Given the rapid evolution of the BioPharma environment in which our clients operate, true business insight is more important than ever,” says Schneider. “I’m delighted to be part of the Ipsos Healthcare team, helping our clients make better commercial decisions by harnessing the strength of Ipsos’ world-class research and syndicated data and providing a clear view of our clients’ customers, their market dynamics and how to bring clarity and optimize brand performance in this complex multi-stakeholder environment.”

Chris Schneider’s market research and commercial strategy experience spans multiple therapy areas including oncology, hematology, supportive care, immunology, virology, and central nervous system disorders. Schneider holds a BS from the U.S. Naval Academy and an MBA from the University of Chicago Graduate School of Business.

For more information on this news release, please contact:

Elen Alexov
Director, Marketing Services
Ipsos in North America
778.373.5136
elen.alexov@ipsos.com

About Ipsos

Ipsos is an independent market research company controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a worldwide research group with a strong presence in all key markets. In October 2011 Ipsos completed the acquisition of Synovate. The combination forms the world’s third largest market research company.

With offices in 85 countries, Ipsos delivers insightful expertise across six research specializations: advertising, customer loyalty, marketing, media, public affairs research, and survey management.

Ipsos researchers assess market potential and interpret market trends. They develop and build brands. They help clients build long- term relationships with their customers. They test advertising and study audience responses to various media and they measure public opinion around the globe.

Ipsos has been listed on the Paris Stock Exchange since 1999 and generated global revenues of €1,789 billion (2.300 billion USD) in 2012.

Visit www.ipsos-na.com to learn more about Ipsos offerings and capabilities.


Ipsos Healthcare Forecasts Stronger Insights for Pharma Companies

Downloads PDF

Press Release

Contact

Elen Alexov
Director, Marketing Services,
North America

Ipsos
1.778.373.5136
elen.alexov@ipsos.com